17 Jul 2019

SENATE BILL TO CUT SURPRISE MEDICAL BILLS AND DRUG PRICES WOULD SAVE U.S. $7 BILLION

The nonpartisan Congressional Budget Office (CBO) says that Senate bill 1895 to tackle surprise medical bills and high drug prices would save the federal government about $7 billion over the next 10 years. The estimate released Tuesday could help the package’s chances for passage through the Senate by easing concerns over the impact

0
16 Jul 2019

MEDICARE ADVANTAGE OVERBILLS TAXPAYERS BY BILLIONS A YEAR AS FEDS STRUGGLE TO STOP IT

          By Fred Schulte and Lauren Weber   Health insurers that treat millions of seniors have overcharged Medicare by nearly $30 billion the past three years alone, but federal officials say they are moving ahead with long-delayed plans to recoup at least part of the money. Officials have known for years

0
12 Jul 2019

PAYER ANALYSIS: ‘CADILLAC TAX’ ON HIGH-COST HEALTH PLANS COULD AFFECT 1 IN 5 EMPLOYERS IN 2022

[/infobox]   A new KFF analysis estimates that the Affordable Care Act’s tax on high-cost health plans would affect one in five (21 percent) employers offering health benefits when it takes effect in 2022 unless employers change their health plans. An even larger share (31 percent) could be affected when workers’ voluntary

0
26 Jun 2019

ROYAL PHILIPS SELLS U.S. HEALTHCARE headquarters

    Amsterdam-based Royal Philips sold its Andover, Mass.-based healthcare headquarters to Atlantic Management Corp. May 4 in a deal worth $36 million. Royal Philips has been transferring its 1,900 employees to facilities in Cambridge, Massachusetts, and Nashville, Tennessee, since January. Atlantic Management, which paid $36 million for the facility,

0
26 Jun 2019

VIVA AND THE VEINS 2019: Dr. Suresh Vedantham to receive VEIN Award; abstracts now being accepted

Suresh Vedantham, MD, past president of the Society of Interventional Radiology, will receive the 2019 Venous Educator, Innovator, and National Statesman Award (VEIN AWARD) during VIVA and The VEINS2019 conference Nov. 4-7 at the Wynn Las Vegas. Dr. Vedantham is a professor of Radiology & Surgery at the Mallinckrodt Institute of Radiology at the

0
26 Jun 2019

 ANGIODYNAMICS SELLS NAMIC fluid management portfolio

AngioDynamics Inc., a provider of innovative, minimally invasive medical devices for oncology, vascular access and peripheral vascular disease, has agreed to sell its NAMIC fluid management portfolio to Medline Industries Inc. for $167.5 million, subject to customary closing conditions including antitrust review under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The

0
26 Jun 2019

CHARING CROSS 2019: MEDTRONIC EXPANDS ON KEY AORTIC SOLUTIONS FOR CHALLENGING ANATOMIES

  Medtronic plc released new data on endovascular repair of abdominal aortic aneurysm (AAA) patients with the Endurant II/IIs stent graft system in combination with Heli-FX EndoAnchor implants and for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR). The data, which was presented at the Charing Cross

0
26 Jun 2019

VEIN SPECIALISTS ADDS NEW NURSE

    Adelene Tolisano, MSN, APRN-C, has joined Vein Specialists in Fort Myers, Florida. Nurse Tolisano assists Joseph Magnant, MD, and his team in performing new patient, pre-operative and post-operative evaluations. She graduated from Florida Southwestern State College where she earned her bachelors in Nursing. She then went on to

0
26 Jun 2019

ABBVIE ACQUIRING ALLERGAN AS HEDGE AGAINST EXPIRATION OF HUMIRA PATENT

As a hedge against the 2023 expiration of its U.S. patents that protect its blockbuster drug, Humira, AbbVie Inc. will acquire Dublin, Ireland-based Allergan for $63 billion in cash and stock.     Humira sales account for more than 60 percent of AbbVie’s revenue, but biosimilar drugs approved in Europe

0
21 Jun 2019

CMS ISSUES RENEWED GUIDANCE IN EFFORT TO ENSURE MEDICAID PROGRAM INTEGRITY

The Centers for Medicare & Medicaid Services (CMS) issued guidance to state Medicaid agencies June 21 that outlines the necessary assurances that states should make to ensure that program resources are reserved for those who meet eligibility requirements. This guidance follows a series of steps that CMS has taken since

0